4th Quarter - Amendment

COVIDIEN LP for COVIDIEN LP

Firm
Client
Income
—
Expenses
$450,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2010 $450,000 Replaced
4th Quarter - Amendment (this page) Jan 27, 2010 $450,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 515/H.R.1260 - Patent Reform Act of 2009

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: Health & Human Services, Dept of (HHS); White House Office; SENATE; Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 515 (111th), H.R. 1260 (111th)

Pharmacy PHA

Issues related to controlled substances, pain and addiction drugs generally.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); SENATE; White House Office; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Issues related to bariatric surgery; comparative effectiveness; S.301 - Physician Payments Sunshine Act of 2009.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); White House Office

Bills named: S. 301 (111th)

Financial Institutions/Investments/Securities FIN

Financial Regulatory Reform- issues relating to derivatives; H.R. 4173 Wall Street Return and Consumer Protection Act.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 4173 (111th)

Taxation/Internal Revenue Code TAX

S. 506 - Stop Tax Haven Abuse Act; H.R. 1265 - Stop Tax Haven Abuse Act; Administration FY 2010 Budget; International tax on foreign direct investment generally.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
WHITNEY GARDINER —

Contacted: SENATE; Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA)

Bills named: S. 506 (111th), H.R. 1265 (111th)

Health Issues HCR

General issues related to healthcare, healthcare reimbursement, and healthcare reform; S. 1213 - Patient Centered Outcomes Research Act; H.R. 2502-Comparative Effectiveness Research Act of 2009; S. 1142 Informed Health Care Decision Making Act. Tri-Committee healthcare reform Proposal; (H.R. 3200, America's Affordable Health Choice Act of 2009) S. 440/H.R. 1346 - Medical Devices Safety Act of 2009; S. 1679 Affordable Health Choice Act; H.R. 3590 Patient Protection and Affordable Care Act of 2009; H.R. 3962 Affordable Healthcare for American Act; S. 1796 "The Americas Healthy Future Act of 2009"; Issues relating to the medical device tax/fee; Senate Finance Committee Healthcare Reform Bill.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); SENATE; White House Office; Food & Drug Administration (FDA)

Bills named: S. 1679 (111th), S. 440 (111th), S. 1796 (111th), H.R. 3962 (111th), H.R. 3590 (111th), H.R. 1346 (111th), H.R. 3200 (111th), S. 1213 (111th), H.R. 2502 (111th), S. 1142 (111th)

Energy/Nuclear ENG

HEU/LEU related issues for nuclear medicine; H.R. 3276 American Medical Isotopes Production Act of 2009.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 3276 (111th)

Budget/Appropriations BUD

H.R. 3288 Fiscal 2010 Omnibus Appropriations; S.Con Res 13; H. Con Res 85; H.R. 1, American Recovery and Reinvestment Act of 2009; H.R. 2346/S. 1054 - Supplemental Appropriations Act (issues relating to pandemic flu); Fiscal 2010 Financial Services Approps.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Office of Science & Technology Policy (OSTP)

Bills named: H.Con.Res. 85 (111th), H.R. 3288 (111th), S.Con.Res. 13 (111th), S. 1054 (111th), H.R. 1 (111th), H.R. 2346 (111th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.